Cargando…

Construction of immune-related and prognostic lncRNA clusters and identification of their immune and genomic alterations characteristics in lung adenocarcinoma samples

Long non-coding RNAs (lncRNAs) play an important role in various biological processes of lung adenocarcinoma (LUAD), such as immune response regulation, tumor microenvironment remodeling and genomic alteration. Nevertheless, immune-related lncRNAs and their immune and genomic alterations characteris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jia, Zhang, Chenyue, Zhang, Chenxing, Wang, Haiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288974/ https://www.ncbi.nlm.nih.gov/pubmed/32445554 http://dx.doi.org/10.18632/aging.103251

Ejemplares similares

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma
por: Jin, Donghui, et al.
Publicado: (2020)

Constructing a prognostic immune-related lncRNA model for colon cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
por: Qi, Xiangjun, et al.
Publicado: (2021)

Patients With BRAF-Mutant NSCLC May Not Benefit From Immune Checkpoint Inhibitors: A Population-Based Study
por: Zhang, Chenxing, et al.
Publicado: (2020)

Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients
por: Liu, Junhui, et al.
Publicado: (2021)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Gastric Cancer
por: Ding, Wei, et al.
Publicado: (2022)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

Genetic alternations and immune characteristics in patients with small cell lung cancer
por: Zhang, Chenyue, et al.
Publicado: (2021)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma
por: Wang, Hao-lun, et al.
Publicado: (2023)

LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022)

Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis
por: Liu, Qingsong, et al.
Publicado: (2022)

Model construction and risk analysis of the lncRNA genes associated with the prognosis of esophageal adenocarcinoma with immune infiltration
por: Lu, Jun, et al.
Publicado: (2023)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Construction and Comprehensive Prognostic Analysis of a Novel Immune-Related lncRNA Signature and Immune Landscape in Gastric Cancer
por: Liang, Xiaolong, et al.
Publicado: (2022)

Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma
por: Li, Jia, et al.
Publicado: (2021)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
por: Wang, Jixin, et al.
Publicado: (2021)

Construction of a 5 immune-related lncRNA-based prognostic model of NSCLC via bioinformatics
por: Huang, Ya-jie, et al.
Publicado: (2021)

Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC
por: Li, Xiawei, et al.
Publicado: (2022)

Construction of a prognostic immune-related lncRNA model and identification of the immune microenvironment in middle- or advanced-stage lung squamous carcinoma patients
por: Xue, Qianqian, et al.
Publicado: (2022)

A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer
por: Sun, Mengyu, et al.
Publicado: (2021)

Identification and Construction of a Predictive Immune-Related lncRNA Signature Model for Melanoma
por: Li, Fang-Wei, et al.
Publicado: (2021)

Construction of an lncRNA model for prognostic prediction of bladder cancer
por: Shi, Changlong, et al.
Publicado: (2022)

LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
por: Lin, Zhichao, et al.
Publicado: (2021)

Development of six immune‐related lncRNA signature prognostic model for smoking‐positive lung adenocarcinoma
por: Zhou, Dajie, et al.
Publicado: (2022)

Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer
por: Zhang, Qiyao, et al.
Publicado: (2021)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma
por: Dai, Wang-Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_638fv94pt3nnfi5j3510honmlm